ロード中...
Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
Until recently, the standard treatment of chronic hepatitis C virus (HCV) infection was a combination therapy with PEG-IFN-α plus ribavirin. Previous studies have proven that several markers predict the outcome of such therapy, e.g., pretreatment plasma levels of interferon inducible protein IP-10,...
保存先:
| 出版年: | Pharmaceuticals (Basel) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4491665/ https://ncbi.nlm.nih.gov/pubmed/26096654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph8020337 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|